Zobrazeno 1 - 10
of 112
pro vyhledávání: '"H, Podder"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
H Podder, Ronald H. Kerman, M. Reyes, Zsolt Káposztás, S. Mauiyyedi, V. Pollard, O. Illoh, Kahan Bd
Publikováno v:
Clinical Transplantation. 23:63-73
Introduction: Antibody mediated rejection (AMR) is associated with a greater incidence of allograft loss because traditional approaches - pulse steroid or anti-lymphocyte antibodies are usually ineffective. This retrospective analysis documented the
Autor:
Stephen M. Katz, C. T. Van Buren, Eva McKissick, A. Lawless, H Podder, Ronald H. Kerman, Richard J. Knight, Barry D. Kahan
Publikováno v:
Clinical Transplantation. 22:645-650
Of 25 simultaneous pancreas-kidney transplant (SPK) recipients treated with thymoglobulin induction, sirolimus and reduced-dose cyclosporine (CsA), 18 low-immune responders (non-African-Americans, PRA < 30%) were withdrawn from prednisone on post-tra
Autor:
H. Podder, B.D. Kahan
Publikováno v:
Transplantation Proceedings. 37:3723-3726
Introduction African-American renal transplant recipients are prone to acute rejection episodes and graft loss owing to genetic, pharmacokinetic, cultural, and socioeconomic factors. While more intense exposures to antirejection agents can mitigate t
Autor:
Robert A. Kirken, Robert M. Langer, Ping Li, Brian Dupre, Lily Feng, Richard A.F. Dixon, Barry D. Kahan, H Podder, Mou-Er Wang, Rongxiang Han, Kurt L. Berens, Stanislaw M. Stepkowski, Wayne W. Hancock
Publikováno v:
Journal of the American Society of Nephrology. 15:2893-2901
Binding of the P-, L-, and E-selectins to sialyl Lewis(x) (sLe(x)) retards circulating leukocytes, thereby facilitating their attachment to the blood vessels of allografts. Whether the selectin inhibitor bimosiamose (BIMO; C(46)H(54)O(16) . 0.25 H(2)
Autor:
Richard J. Knight, Charles T. Van Buren, Ronald H. Kerman, H Podder, Stephen M. Katz, Barry D. Kahan, L. Schoenberg
Publikováno v:
Transplantation. 78:904-910
Background. We previously reported that the use of basiliximab together with sirolimus permits a window of recovery from delayed graft function before the introduction of reduced-dose cyclosporine. The present study reviews our experience with the su
Autor:
H Podder, Richard J. Knight, Stephen M. Katz, Ronald H. Kerman, C. T. Van Buren, Barry D. Kahan
Publikováno v:
Transplantation Proceedings. 37:1280-1282
Our objective was to determine the impact of thymoglobulin-sirolimus-cyclosporine immunosuppression on the alloimmune response of pancreas-kidney transplant recipients.Thirty-six pancreas transplant recipients received an induction protocol of thymog
Autor:
R J, Knight, R H, Kerman, E, McKissick, A, Lawless, H, Podder, S, Katz, C T, Van Buren, B D, Kahan
Publikováno v:
Clinical transplantation. 22(5)
Of 25 simultaneous pancreas-kidney transplant (SPK) recipients treated with thymoglobulin induction, sirolimus and reduced-dose cyclosporine (CsA), 18 low-immune responders (non-African-Americans, PRA30%) were withdrawn from prednisone on post-transp
Autor:
L. Schoenberg, Charles T. Van Buren, H Podder, Richard J. Knight, Z Csapo, Ronald H. Kerman, Barry D. Kahan, Stephen M. Katz
Publikováno v:
Clinical transplantation. 20(4)
Aim: To compare the outcomes of single paediatric vs. adult kidneys transplanted into adult recipients, Methods: A retrospective single-centre review of 38 single cadaver kidney transplants from donors less than five yr of age to wait-listed patients
Autor:
Charles T. Van Buren, Stephen M. Katz, Ronald H. Kerman, Scott Zela, Jeannette Podbielski, Richard J. Knight, H Podder, Barry D. Kahan
Publikováno v:
Transplantation. 81(8)
This study aims to determine the impact of thymoglobulin-sirolimus-cyclosporine immunosuppression on the alloimune response of pancreas-kidney transplant recipients.Thirty-six pancreas transplant recipients received an induction protocol of thymoglob